DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.

J Transl Med · 2015 · PMC4619378 · PMID 26496879

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In BRCA1 mutation carriers with IBC + DCIS, the correlation between the DCIS and IBC (Tables 2 , 3 ) was highly significant for ER, PR, HER1, HER3 (Fig. 3 ), and C-MET (Fig. 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.